Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Richard Liebano
This study aimed to assess the effectiveness of interferential current (IFC) therapy in alleviating symptoms and improving functional outcomes in patients experiencing persistent non-specific low back pain. A randomized controlled trial was conducted involving participants aged [18-65] with a diagnosis of on-going non-specific low back pain. Participants were randomly assigned to either the IFC intervention group or a control group receiving standard care. The IFC group received, while the control group continued with their routine care, which included [describe standard care, e.g., medications, physical therapy]. Outcome measures included pain intensity, functional disability, and health-related quality of life, assessed at baseline, post-treatment, and follow-up intervals. The study demonstrated a significant reduction in pain intensity and functional disability in the IFC group compared to the control group (p < 0.05). Moreover, participants in the IFC group reported improvements in health-related quality of life at follow-up assessments. The intervention was well-tolerated, with no reported adverse effects. Interferential current therapy emerged as an effective adjunctive treatment for individuals with on-going nonspecific low back pain, contributing to pain reduction, improved functionality, and enhanced quality of life. These findings support the integration of IFC into comprehensive pain management strategies for individuals grappling with persistent low back pain. Further research exploring long-term effects and optimal treatment parameters is warranted to refine clinical recommendations.